This can have major implications because around 30.6 million Americans live with Type 2 diabetes. Lizaola-Mayo emphasizes that the number one risk factor for fatty liver disease is Type 2 diabetes. While there may not be signs, there are well-defined risk factors that may help determine if you need to be screened for NAFLD or NASH. So they are presenting for care when they have decompensated liver failure or even liver cancer,” explains Lizaola-Mayo. “Patients do not know they have it and it does not hurt. Occasionally, one may have pain in the right upper side of the abdomen. Most of the time, a “fatty liver” does not cause any symptoms in its early stages. She walks us through everything you need to know about NASH. In its most severe form, it can be fatal.īut Lizaola-Mayo wants you to know it is treatable and reversible when it is caught early. NASH occurs when a “fatty liver” or nonalcoholic fatty liver disease (NAFLD) leads to inflammation and liver cell damage called fibrosis. Blanca Lizaola-Mayo, MD, a transplant hepatologist and the Medical Director of the Liver Transplant Center at the Mayo Clinic in Arizona, is sounding the alarm on NASH or nonalcoholic steatohepatitis. It is projected to be the number one cause of liver transplantation in the United States by the year 2030. And it’s rising in children.ĭr.
It’s often, “silent” – meaning it rarely presents with symptoms.
0 kommentar(er)
